• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

骨硬化蛋白抗体治疗可增强大鼠骺骨愈合。

Sclerostin antibody treatment enhances metaphyseal bone healing in rats.

机构信息

Orthopedics, Department of Clinical and Experimental Medicine, Faculty of Medicine, Linköping University, Linköping, Sweden.

出版信息

J Bone Miner Res. 2010 Nov;25(11):2412-8. doi: 10.1002/jbmr.135.

DOI:10.1002/jbmr.135
PMID:20499342
Abstract

Sclerostin is the product of the SOST gene. Loss-of-function mutations in the SOST gene result in a high-bone-mass phenotype, demonstrating that sclerostin is a negative regulator of bone mass. Primarily expressed by osteocytes in bone, sclerostin is reported to bind the LRP5/6 receptor, thereby antagonizing canonical Wnt signaling and negatively regulating bone formation. We therefore investigated whether systemic administration of a sclerostin-neutralizing antibody would increase the regeneration of traumatized metaphyseal bone in rats. Young male rats had a screw inserted in the proximal tibia and were divided into six groups given 25 mg/kg of sclerostin antibody or control twice a week subcutaneously for 2 or 4 weeks. In four groups, the screws were tested for pull-out strength. At the time of euthanasia, a similar screw also was inserted in the contralateral tibia and pull-out tested immediately. Sclerostin antibody significantly increased the pull-out force by almost 50% compared with controls after 2 and 4 weeks. Also, the screws inserted at the time of euthanasia showed increased pull-out force. Micro-computed tomography (µCT) of the remaining two groups showed that the antibody led to a 30% increase in bone volume fraction in a region surrounding the screw. There also was a general increase in trabecular thickness in cancellous bone. Thus, as measured by the amount of bone and its mechanical resistance, the sclerostin antibody increased bone formation during metaphyseal repair but also in untraumatized bone.

摘要

骨硬化蛋白是 SOST 基因的产物。SOST 基因的功能丧失性突变导致骨量高的表型,表明骨硬化蛋白是骨量的负调节剂。骨硬化蛋白主要由骨细胞表达,据报道它与 LRP5/6 受体结合,从而拮抗经典 Wnt 信号通路并负调控骨形成。因此,我们研究了全身性给予骨硬化蛋白中和抗体是否会增加大鼠创伤性干骺端骨的再生。年轻雄性大鼠的胫骨近端插入一根螺钉,并分为六组,每周两次皮下给予 25mg/kg 的骨硬化蛋白抗体或对照 2 或 4 周。在四组中,测试螺钉的拔出强度。在安乐死时,在对侧胫骨中也插入了类似的螺钉,并立即进行拔出测试。与对照组相比,骨硬化蛋白抗体在 2 周和 4 周后分别使拔出力增加了近 50%。此外,在安乐死时插入的螺钉显示出增加的拔出力。对其余两组的 micro-CT(µCT)进行分析显示,抗体使螺钉周围区域的骨体积分数增加了 30%。松质骨的小梁厚度也普遍增加。因此,根据骨量及其机械阻力的大小,骨硬化蛋白抗体增加了干骺端修复期间的骨形成,也增加了未受创伤的骨的骨形成。

相似文献

1
Sclerostin antibody treatment enhances metaphyseal bone healing in rats.骨硬化蛋白抗体治疗可增强大鼠骺骨愈合。
J Bone Miner Res. 2010 Nov;25(11):2412-8. doi: 10.1002/jbmr.135.
2
Efficacy of a sclerostin antibody compared to a low dose of PTH on metaphyseal bone healing.成骨素抗体与低剂量甲状旁腺激素在干骺端骨愈合中的疗效比较。
J Orthop Res. 2014 Mar;32(3):471-6. doi: 10.1002/jor.22525. Epub 2013 Nov 14.
3
The effects of Dickkopf-1 antibody on metaphyseal bone and implant fixation under different loading conditions.不同受力条件下 Dickkopf-1 抗体对骺骨和种植体固定的影响。
Bone. 2011 May 1;48(5):988-96. doi: 10.1016/j.bone.2011.02.008. Epub 2011 Feb 15.
4
Anti-sclerostin antibody and mechanical loading appear to influence metaphyseal bone independently in rats.抗硬骨素抗体和机械加载似乎独立影响大鼠干骺端骨。
Acta Orthop. 2011 Oct;82(5):628-32. doi: 10.3109/17453674.2011.625539.
5
Sclerostin antibody treatment increases bone formation, bone mass, and bone strength in a rat model of postmenopausal osteoporosis.硬化蛋白抗体治疗可增加绝经后骨质疏松大鼠模型的骨形成、骨量和骨强度。
J Bone Miner Res. 2009 Apr;24(4):578-88. doi: 10.1359/jbmr.081206.
6
Sclerostin antibody prevented progressive bone loss in combined ovariectomized and concurrent functional disuse.硬化蛋白抗体可预防卵巢切除联合同时期功能性废用导致的进行性骨质流失。
Bone. 2016 Jun;87:161-8. doi: 10.1016/j.bone.2016.02.005. Epub 2016 Feb 8.
7
Temporal changes in systemic and local expression of bone turnover markers during six months of sclerostin antibody administration to ovariectomized rats.在给去卵巢大鼠注射硬化蛋白抗体的六个月期间,骨转换标志物的全身和局部表达的时间变化。
Bone. 2014 Oct;67:305-13. doi: 10.1016/j.bone.2014.07.031. Epub 2014 Aug 2.
8
Inhibition of sclerostin by systemic treatment with sclerostin antibody enhances healing of proximal tibial defects in ovariectomized rats.系统性抑制硬化蛋白治疗可增强去卵巢大鼠胫骨近端缺损的愈合。
J Orthop Res. 2012 Oct;30(10):1541-8. doi: 10.1002/jor.22109. Epub 2012 Mar 27.
9
Sclerostin antibody treatment improves bone mass, bone strength, and bone defect regeneration in rats with type 2 diabetes mellitus.骨硬化蛋白抗体治疗可改善 2 型糖尿病大鼠的骨量、骨强度和骨缺损再生。
J Bone Miner Res. 2013 Mar;28(3):627-38. doi: 10.1002/jbmr.1803.
10
Sclerostin antibody enhances bone formation in a rat model of distraction osteogenesis.硬化素抗体可增强大鼠牵张成骨模型中的骨形成。
J Orthop Res. 2018 Apr;36(4):1106-1113. doi: 10.1002/jor.23726. Epub 2018 Feb 1.

引用本文的文献

1
Sclerostin antibody enhances implant osseointegration in bone with Col1a1 mutation.骨硬化蛋白抗体增强 Col1a1 突变骨中的种植体骨整合。
Bone. 2024 Sep;186:117167. doi: 10.1016/j.bone.2024.117167. Epub 2024 Jun 13.
2
Impact of osteoporosis and osteoporosis medications on fracture healing: a narrative review.骨质疏松症及骨质疏松症药物对骨折愈合的影响:叙述性综述。
Osteoporos Int. 2024 Aug;35(8):1337-1358. doi: 10.1007/s00198-024-07059-8. Epub 2024 Apr 8.
3
Mineral coated microparticles doped with fluoride and complexed with mRNA prolong transfection in fracture healing.
掺杂氟化物并与信使核糖核酸(mRNA)复合的矿物涂层微粒可延长骨折愈合中的转染时间。
Front Bioeng Biotechnol. 2024 Jan 9;11:1295313. doi: 10.3389/fbioe.2023.1295313. eCollection 2023.
4
Muscle-bone crosstalk via endocrine signals and potential targets for osteosarcopenia-related fracture.通过内分泌信号的肌肉-骨骼相互作用以及骨质疏松性肌少症相关骨折的潜在靶点
J Orthop Translat. 2023 Nov 5;43:36-46. doi: 10.1016/j.jot.2023.09.007. eCollection 2023 Nov.
5
Advances in Osteoporosis Therapy: Focus on Osteoanabolic Agents, Secondary Fracture Prevention, and Perioperative Bone Health.骨质疏松症治疗进展:关注骨合成代谢药物、二次骨折预防和围手术期骨骼健康。
Curr Osteoporos Rep. 2023 Aug;21(4):386-400. doi: 10.1007/s11914-023-00793-8. Epub 2023 Jun 8.
6
Antisclerostin Effect on Osseointegration and Bone Remodeling.抗硬化蛋白对骨整合和骨重塑的影响。
J Clin Med. 2023 Feb 6;12(4):1294. doi: 10.3390/jcm12041294.
7
Endocrine Functions of Sclerostin.硬化蛋白的内分泌功能。
Curr Opin Endocr Metab Res. 2023 Feb;28. doi: 10.1016/j.coemr.2022.100433.
8
Management of Osteoporosis Medication after Osteoporotic Fracture.骨质疏松性骨折后骨质疏松症药物治疗
Hip Pelvis. 2022 Dec;34(4):191-202. doi: 10.5371/hp.2022.34.4.191. Epub 2022 Dec 3.
9
Novel Biomarkers Predictive of Diabetic Charcot Foot-An Overview of the Literature.预测糖尿病夏科氏足的新型生物标志物——文献综述
Life (Basel). 2022 Nov 21;12(11):1944. doi: 10.3390/life12111944.
10
Therapeutic approaches to activate the canonical Wnt pathway for bone regeneration.激活经典 Wnt 通路促进骨再生的治疗方法。
J Tissue Eng Regen Med. 2022 Nov;16(11):961-976. doi: 10.1002/term.3349. Epub 2022 Sep 16.